These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11092525)

  • 21. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers.
    Satoh A; Toyota M; Itoh F; Kikuchi T; Obata T; Sasaki Y; Suzuki H; Yawata A; Kusano M; Fujita M; Hosokawa M; Yanagihara K; Tokino T; Imai K
    Br J Cancer; 2002 Jun; 86(11):1817-23. PubMed ID: 12087472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.
    Ng MH; To KW; Lo KW; Chan S; Tsang KS; Cheng SH; Ng HK
    Clin Cancer Res; 2001 Jun; 7(6):1724-9. PubMed ID: 11410512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
    Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
    Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
    J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
    Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum.
    Yamaguchi S; Asao T; Nakamura J; Ide M; Kuwano H
    Cancer Lett; 2003 May; 194(1):99-105. PubMed ID: 12706863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma.
    Takakuwa T; Hongyo T; Syaifudin M; Kanno H; Matsuzuka F; Narabayashi I; Nomura T; Aozasa K
    Jpn J Cancer Res; 2000 Mar; 91(3):280-6. PubMed ID: 10760686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.
    Rossi D; Gaidano G; Gloghini A; Deambrogi C; Franceschetti S; Berra E; Cerri M; Vendramin C; Conconi A; Viglio A; Muti G; Oreste P; Morra E; Paulli M; Capello D; Carbone A
    Br J Haematol; 2003 Nov; 123(3):475-8. PubMed ID: 14617009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.
    Chim CS; Fung TK; Wong KF; Lau JS; Liang R
    J Hum Genet; 2006; 51(9):832-838. PubMed ID: 16897188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer.
    Sobti RC; MalekZadeh K; Nikbakht M; Sadeghi IA; Shekari M; Singh SK
    Biomarkers; 2010 Mar; 15(2):167-74. PubMed ID: 19958159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA sequence of immunoglobulin heavy chain variable region gene in thyroid lymphoma.
    Miwa H; Takakuwa T; Nakatsuka S; Tomita Y; Matsuzuka F; Aozasa K
    Jpn J Cancer Res; 2001 Oct; 92(10):1041-7. PubMed ID: 11676854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of death-associated protein kinase in ovarian carcinomas.
    Collins Y; Dicioccio R; Keitz B; Lele S; Odunsi K
    Int J Gynecol Cancer; 2006; 16 Suppl 1():195-9. PubMed ID: 16515590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
    Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
    Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.
    Tada Y; Wada M; Taguchi K; Mochida Y; Kinugawa N; Tsuneyoshi M; Naito S; Kuwano M
    Cancer Res; 2002 Jul; 62(14):4048-53. PubMed ID: 12124340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant somatic hypermutations in thyroid lymphomas.
    Takakuwa T; Miyauchi A; Aozasa K
    Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA hypermethylation status of multiple genes in soft tissue sarcomas.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Kobayashi C; Tamiya S; Tateishi N; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Jan; 19(1):106-14. PubMed ID: 16258501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymerase chain reaction-based clonality analysis in thyroid lymphoma.
    Yamauchi A; Tomita Y; Takakuwa T; Hoshida Y; Nakatsuka S; Sakamoto H; Aozasa K
    Int J Mol Med; 2002 Jul; 10(1):113-7. PubMed ID: 12060861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.